Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

UKONS 2018 | Real world assessment of lenalidomide toxicity in elderly relapsed myeloma

Faouzi Djebbari • 16 Nov 2018
UKONS 2018
Multiple Myeloma Lenalidomide

Faouzi Djebbari, MPharm (Hons), MSc, of Oxford University Hospitals NHS Trust, Oxford, UK, discusses his work investigating the risk of lenalidomide toxicity in older patients with relapsed multiple myeloma. He also highlights his plans for further study in this area. This interview was recorded at the UK Oncology Nursing Society (UKONS) 2018 Annual Conference, held in Glasgow, UK.

Related Videos

When can sustained MRD negativity guide treatment de-escalation in high-risk myeloma?
0:51
When can sustained MRD negativity guide treatment de-escalation in high-risk myeloma?
Benjamin Diamond • 23 Oct 2026
Should MRD negativity guide treatment de-escalation in high-risk myeloma?
0:43
Should MRD negativity guide treatment de-escalation in high-risk myeloma?
Benjamin Diamond • 23 Oct 2026
Integrating MRD and genomic profiling to guide treatment in high-risk myeloma
0:47
Integrating MRD and genomic profiling to guide treatment in high-risk myeloma
Benjamin Diamond • 23 Oct 2026
Practical approaches to MRD and genomic testing in myeloma
0:55
Practical approaches to MRD and genomic testing in myeloma
Benjamin Diamond • 23 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals